ArticleEcancermedicalscience2024

Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world data.

Vanita Noronha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.